These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9463404)

  • 1. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.
    Segal BM; Dwyer BK; Shevach EM
    J Exp Med; 1998 Feb; 187(4):537-46. PubMed ID: 9463404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-bet is essential for the progression of experimental autoimmune encephalomyelitis.
    Nath N; Prasad R; Giri S; Singh AK; Singh I
    Immunology; 2006 Jul; 118(3):384-91. PubMed ID: 16827899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytokine signature of MOG-specific CD4 cells in the EAE of C57BL/6 mice.
    Hofstetter HH; Karulin AY; Forsthuber TG; Ott PA; Tary-Lehmann M; Lehmann PV
    J Neuroimmunol; 2005 Dec; 170(1-2):105-14. PubMed ID: 16257061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
    Cua DJ; Coffman RL; Stohlman SA
    J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
    Krakowski ML; Owens T
    Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells.
    Chang JT; Shevach EM; Segal BM
    J Exp Med; 1999 Mar; 189(6):969-78. PubMed ID: 10075980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-dihydroxyvitamin D
    Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
    Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-associated changes in rat immune system: lessons learned from experimental autoimmune encephalomyelitis.
    Djikić J; Nacka-Aleksić M; Pilipović I; Stojić-Vukanić Z; Bufan B; Kosec D; Dimitrijević M; Leposavić G
    Exp Gerontol; 2014 Oct; 58():179-97. PubMed ID: 25128713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl fumarate-induced IL-17
    Brück J; Glocova I; Geisel J; Kellerer C; Röcken M; Ghoreschi K
    Eur J Immunol; 2018 Sep; 48(9):1588-1591. PubMed ID: 30007005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination.
    Gran B; Zhang GX; Rostami A
    Crit Rev Immunol; 2004; 24(2):111-28. PubMed ID: 15581393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
    Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
    Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway.
    Kroenke MA; Segal BM
    Brain Behav Immun; 2011 Jul; 25(5):932-7. PubMed ID: 20951792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
    Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
    Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice.
    Shibuya K; Robinson D; Zonin F; Hartley SB; Macatonia SE; Somoza C; Hunter CA; Murphy KM; O'Garra A
    J Immunol; 1998 Feb; 160(4):1708-16. PubMed ID: 9469428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.